Literature DB >> 21949249

The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling.

Kristopher Clark1, Osamu Takeuchi, Shizuo Akira, Philip Cohen.   

Abstract

Toll-like receptor (TLR) ligands that signal via TIR-domain-containing adapter-inducing IFNβ (TRIF) activate the IκB kinase (IKK)-related kinases, TRAF associated NFκB activator (TANK)-binding kinase-1 (TBK1) and IKKε, which then phosphorylate IRF3 and induce the production of IFNβ. Here we show that TBK1 and IKKε are also activated by TLR ligands that signal via MyD88. Notably, the activation of IKKε is rapid, transient, and it precedes a more prolonged activation of TBK1. The MyD88- and TRIF-dependent signaling pathways activate the IKK-related kinases by two signaling pathways. One is mediated by the canonical IKKs, whereas the other culminates in the autoactivation of the IKK-related kinases. Once activated, TBK1/IKKε then phosphorylate and inhibit the canonical IKKs. The negative regulation of the canonical IKKs by the IKK-related kinases occurs in both the TRIF- and MyD88-dependent TLR pathways, whereas IRF3 phosphorylation is restricted to the TRIF-dependent signaling pathway. We have discovered that the activation of IKKε is abolished, the activation of TBK1 is reduced, and the interaction between the IKK-related kinases and the canonical IKKs is suppressed in TANK(-/-) macrophages, preventing the IKK-related kinases from negatively regulating the canonical IKKs. In contrast, IRF3 phosphorylation and IFNβ production was normal in TANK(-/-) macrophages. Our results demonstrate a key role for TANK in enabling the canonical IKKs and the IKK-related kinases to regulate each other, which is required to limit the strength of TLR signaling and ultimately, prevent autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21949249      PMCID: PMC3193242          DOI: 10.1073/pnas.1114194108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK.

Authors:  C Wang; L Deng; M Hong; G R Akkaraju; J Inoue ; Z J Chen
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

3.  NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.

Authors:  J L Pomerantz; D Baltimore
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

4.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta.

Authors:  Jonathan C Kagan; Tian Su; Tiffany Horng; Amy Chow; Shizuo Akira; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-02-24       Impact factor: 25.606

Review 5.  Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?

Authors:  Tieu-Lan Chau; Romain Gioia; Jean-Stéphane Gatot; Félicia Patrascu; Isabelle Carpentier; Jean-Paul Chapelle; Luke O'Neill; Rudi Beyaert; Jacques Piette; Alain Chariot
Journal:  Trends Biochem Sci       Date:  2008-03-18       Impact factor: 13.807

6.  Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation.

Authors:  Kristopher Clark; Lorna Plater; Mark Peggie; Philip Cohen
Journal:  J Biol Chem       Date:  2009-03-22       Impact factor: 5.157

7.  Novel cross-talk within the IKK family controls innate immunity.

Authors:  Kristopher Clark; Mark Peggie; Lorna Plater; Ronald J Sorcek; Erick R R Young; Jeffrey B Madwed; Joanne Hough; Edward G McIver; Philip Cohen
Journal:  Biochem J       Date:  2011-02-15       Impact factor: 3.857

8.  TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis.

Authors:  Tatsukata Kawagoe; Osamu Takeuchi; Yoshitsugu Takabatake; Hiroki Kato; Yoshitaka Isaka; Tohru Tsujimura; Shizuo Akira
Journal:  Nat Immunol       Date:  2009-08-09       Impact factor: 25.606

9.  Polyubiquitin binding to ABIN1 is required to prevent autoimmunity.

Authors:  Sambit K Nanda; Ram K C Venigalla; Alban Ordureau; Janet C Patterson-Kane; David W Powell; Rachel Toth; J Simon C Arthur; Philip Cohen
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

10.  Direct activation of protein kinases by unanchored polyubiquitin chains.

Authors:  Zong-Ping Xia; Lijun Sun; Xiang Chen; Gabriel Pineda; Xiaomo Jiang; Anirban Adhikari; Wenwen Zeng; Zhijian J Chen
Journal:  Nature       Date:  2009-08-12       Impact factor: 49.962

View more
  62 in total

Review 1.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

2.  TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation.

Authors:  Bart Everts; Eyal Amiel; Stanley Ching-Cheng Huang; Amber M Smith; Chih-Hao Chang; Wing Y Lam; Veronika Redmann; Tori C Freitas; Julianna Blagih; Gerritje J W van der Windt; Maxim N Artyomov; Russell G Jones; Erika L Pearce; Edward J Pearce
Journal:  Nat Immunol       Date:  2014-02-23       Impact factor: 25.606

3.  Upregulation of PD-L1 via HMGB1-Activated IRF3 and NF-κB Contributes to UV Radiation-Induced Immune Suppression.

Authors:  Wei Wang; Nicole M Chapman; Bo Zhang; Mingqi Li; Meiyun Fan; R Nicholas Laribee; M Raza Zaidi; Lawrence M Pfeffer; Hongbo Chi; Zhao-Hui Wu
Journal:  Cancer Res       Date:  2019-02-08       Impact factor: 12.701

4.  An alternative model for type I interferon induction downstream of human TLR2.

Authors:  Timo Oosenbrug; Michel J van de Graaff; Mariëlle C Haks; Sander van Kasteren; Maaike E Ressing
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

5.  Innate Immune Signaling Organelles Display Natural and Programmable Signaling Flexibility.

Authors:  Yunhao Tan; Jonathan C Kagan
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

6.  STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway.

Authors:  Yasuo Tanaka; Zhijian J Chen
Journal:  Sci Signal       Date:  2012-03-06       Impact factor: 8.192

7.  Cellular FLIP long isoform (cFLIPL)-IKKα interactions inhibit IRF7 activation, representing a new cellular strategy to inhibit IFNα expression.

Authors:  Lauren T Gates-Tanzer; Joanna L Shisler
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

8.  Fascin1 suppresses RIG-I-like receptor signaling and interferon-β production by associating with IκB kinase ϵ (IKKϵ) in colon cancer.

Authors:  Tomio Matsumura; Shigeaki Hida; Masato Kitazawa; Chifumi Fujii; Akira Kobayashi; Michiko Takeoka; Shun-Ichiro Taniguchi; Shin-Ichi Miyagawa
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

9.  Structure and ubiquitination-dependent activation of TANK-binding kinase 1.

Authors:  Daqi Tu; Zehua Zhu; Alicia Y Zhou; Cai-hong Yun; Kyung-Eun Lee; Angela V Toms; Yiqun Li; Gavin P Dunn; Edmond Chan; Tran Thai; Shenghong Yang; Scott B Ficarro; Jarrod A Marto; Hyesung Jeon; William C Hahn; David A Barbie; Michael J Eck
Journal:  Cell Rep       Date:  2013-02-28       Impact factor: 9.423

10.  Human DEAD box helicase 3 couples IκB kinase ε to interferon regulatory factor 3 activation.

Authors:  Lili Gu; Anthony Fullam; Ruth Brennan; Martina Schröder
Journal:  Mol Cell Biol       Date:  2013-03-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.